ATRA - Atara Biotherapeutics

Exchange: NASDAQ

ATRA - Atara Biotherapeutics

Exchange: NASDAQ
#4207()/7029

Tue 31'st Jul 2018

PERIOD 2018-05-02 - 2018-07-31
CHANGE 4.74%
PRICE $37.55
VOLUME
Sell
TREND
Sell

MV LONG
Sell

MV SHORT
Sell

PIVOT
Buy

MACD
Buy

0.00%

Atara Biotherapeutics Stock Analysis

Technical stock analysis for Tue 31'st Jul 2018

Sell candidate since 2018-07-18 Loss -5.77%
Shorts 10.21% ( 2018-07-13 )
Cash 417.1 mill
Loans n/a
Beta 2.54
ROA -37.85

Atara Biotherapeutics gained 4.74% in the last trading day, rising from $35.85 to $37.55 The price has fallen in 7 of the last 10 days and is down by -7.28% for this period. Volume fell in the last day by -361 145 shares, and in total, 414 908 shares bought and sold for approximately $15.58 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Trend

Atara Biotherapeutics lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.05% during the next 3 months and, with 90% probability hold a price between $26.47 and $37.53 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

A buy signal was issued from a pivot bottom point on Monday July 30, 2018, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Atara Biotherapeutics holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $38.11 and $40.58. A break-up above any of these levels will issue buy signals.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 40 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Atara Biotherapeutics finds support from accumulated volume at $36.75.

Support: $36.75 Price: $37.55 Resistance: $39.85

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $1.90 (5.32%) between high and low. For the last week, the stock has had a daily average volatility of 5.48%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation

Atara Biotherapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.

Sell Candidate

Click for Top 5 Sell Candidates

Hot Trends

exxon mobil xom jcpenney stock price should i invest in ford stock exxon mobil will bank of america stock go up top stocks to invest in short term how to buy stock from amazon prudential financial stocks ford share price today should i buy chesapeake energy stock how high is tesla stock expected to go at&t sold amazon technical analysis msft stock today stocks to invest in this week prudential share price chart
Help us IMPROVE our CHARTS HERE.

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at


in partnership with
START FREE 5-DAY TRIAL